about
Isolation of tumorigenic circulating melanoma cellsModulation of T-cell activation by malignant melanoma initiating cellsABCB5 identifies a therapy-refractory tumor cell population in colorectal cancer patientsABCB5 maintains melanoma-initiating cells through a proinflammatory cytokine signaling circuitThe therapeutic promise of the cancer stem cell concept.Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanomaInterleukin-10+ regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigensColorectal Cancer Stem Cells: Biology and Therapeutic Implications.Nestin depletion induces melanoma matrix metalloproteinases and invasionCombined Inhibition of MEK and Plk1 Has Synergistic Antitumor Activity in NRAS Mutant Melanoma.Regulation of myogenic progenitor proliferation in human fetal skeletal muscle by BMP4 and its antagonist GremlinMelanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth.Cancer stem cells and human malignant melanomaEffects of Malignant Melanoma Initiating Cells on T-Cell ActivationMelanoma stem cells and metastasis: mimicking hematopoietic cell trafficking?Tumor-infiltrating lymphocytes and their significance in melanoma prognosis.Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy.ABCB5-Targeted Chemoresistance Reversal Inhibits Merkel Cell Carcinoma Growth.T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy.Merkel cell carcinoma expresses vasculogenic mimicry: demonstration in patients and experimental manipulation in xenografts.Metabolic inhibition of galectin-1-binding carbohydrates accentuates antitumor immunity.Homing in on the Sweet Side of Immune Checkpoint Biology.Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal Adenocarcinoma.Antitumor immunity and cancer stem cellsMelanoma Cell Galectin-1 Ligands Functionally Correlate with Malignant PotentialThe in vitro spheroid melanoma cell culture assay: cues on tumor initiation?Tumor dormancy and cancer stem cells: two sides of the same coin?In vivo function of immune inhibitory molecule B7-H4 in alloimmune responses.PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinomaP-glycoprotein functions as a differentiation switch in antigen presenting cell maturation
P50
Q24569644-13504098-834B-4C3C-B1BF-F631EE16F060Q24595394-2200C114-CF04-4D22-9E25-927D4B53934DQ24632539-3ABE48F7-9DC4-4663-B50A-3B0B99053C27Q28242049-7AB78AE5-D5FD-465C-90C7-B78AFC894D28Q33559711-D8876C76-32C6-4619-9D7D-B3580688DCEEQ34299814-C0209DB0-BDFD-4001-99EA-64D23E981DF4Q34762482-4EB83F52-D73F-40CC-B3B3-AF66935EF193Q34921375-47D2989E-28D4-4D2F-8ACA-7D7950B69796Q35569170-C5B98243-87F3-40DC-A5AE-D9F4359B8F7AQ36054290-F31465FF-10FD-4384-AB4D-679311040A5DQ36118952-051A86BA-0890-449C-988D-3EBDCA9AD285Q36429062-545218DC-F904-47AC-B447-0D0C861D6FDCQ37114128-FD3F9753-2AB1-48D8-A58A-C08261905543Q37116163-2EA67D99-8655-431F-BF88-C697D4D6A8ECQ37615286-A7A70F39-DC4F-44DA-AE6D-3A4DD3908C46Q38164610-6584C87A-C70D-4BF8-83FA-AFC8D358CC02Q38791328-0871C3CE-016D-4360-AD89-FF8FBFC431C1Q38797966-79A35A0A-53F1-4C9D-9F95-88129EEE334CQ38873974-18DFAEF4-AD7D-4D04-B89E-7E1E6A8499FFQ38967137-024BB20A-A53B-4CE3-9056-7F759EDFFBCBQ40401752-7E27789B-EF67-4637-A6D2-2E084EABB5EBQ40669507-F7E01A70-3C98-443E-984F-16AC204E771CQ41204382-A39B7D7C-ED42-44A3-8D6E-CE70A2A64B90Q41520738-3722160C-3727-4706-8BB4-086DCCF066E0Q41780259-3D8EFD86-B582-48BA-A1B1-A02FFBECBDF8Q42734456-6D0A8370-FB4E-4A83-9FF8-AE13E5320F1BQ44931785-3319D4C0-EFB3-4121-901F-B28A90E558C5Q45039595-08813B66-D529-48DF-B1FE-150C5ED8A2FBQ62888577-B2B036D0-9D28-495E-AD35-3CD53DF1F994Q79327750-F5D1E7A3-74BE-43D2-B948-2AF4538057D0
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Tobias Schatton
@ast
Tobias Schatton
@en
Tobias Schatton
@es
Tobias Schatton
@nl
type
label
Tobias Schatton
@ast
Tobias Schatton
@en
Tobias Schatton
@es
Tobias Schatton
@nl
prefLabel
Tobias Schatton
@ast
Tobias Schatton
@en
Tobias Schatton
@es
Tobias Schatton
@nl
P106
P21
P31
P496
0000-0003-1386-680X